Nathaniel M Weathington Selected Research

Nathaniel M Weathington Research Topics

Disease

9	Inflammation (Inflammations) 01/2020 - 03/2006
7	Infections 01/2017 - 02/2009
4	Lung Diseases (Lung Disease) 11/2021 - 05/2010
4	Pneumonia (Pneumonitis) 07/2019 - 01/2015
3	Lung Injury 01/2020 - 10/2015
2	Asthma (Bronchial Asthma) 11/2021 - 01/2012
2	Neoplasms (Cancer) 01/2014 - 09/2013
2	Cystic Fibrosis (Mucoviscidosis) 01/2012 - 05/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2009 - 09/2008
1	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 11/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2019
1	Critical Illness (Critically Ill) 12/2019
1	Acute Kidney Injury (Acute Renal Failure) 12/2019
1	Acute Lung Injury 07/2019
1	Virus Diseases (Viral Diseases) 10/2017
1	Shock 07/2015
1	Pulmonary Edema 07/2015
1	Cytokine Release Syndrome 07/2015
1	Human Influenza (Influenza) 01/2015
1	Bacteremia 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Starvation 11/2014
1	Neoplasm Metastasis (Metastasis) 11/2014
1	Multiple Myeloma 01/2014
1	Viral Pneumonia 11/2013
1	Septic Shock (Toxic Shock Syndrome) 11/2013
1	Colitis 11/2013
1	Disease Progression 02/2009
1	Emphysema 09/2008
1	Fatigue 03/2007
1	Myasthenia Gravis 03/2007
1	Muscle Weakness 03/2007
1	Neointima 09/2004
1	Autoimmune Diseases (Autoimmune Disease) 02/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2013
4	CytokinesIBA 07/2015 - 02/2009
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2018 - 01/2015
3	UbiquitinIBA 07/2015 - 09/2013
3	Peptide Hydrolases (Proteases)FDA Link 01/2012 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 03/2006
2	Messenger RNA (mRNA)IBA 01/2017 - 11/2014
2	LipopolysaccharidesIBA 10/2015 - 07/2015
2	InterleukinsIBA 01/2015 - 06/2014
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2014 - 09/2013
2	VaccinesIBA 03/2007 - 02/2003
1	Small Cytoplasmic RNAIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Cyclic AMP (AMP, Cyclic)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Deubiquitinating EnzymesIBA 07/2019
1	Interleukin-1 (Interleukin 1)IBA 07/2019
1	Interferon gamma ReceptorIBA 10/2017
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	InflammasomesIBA 01/2017
1	AnticoagulantsIBA 10/2015
1	Histones (Histone)IBA 10/2015
1	argatroban (MPQA)FDA Link 10/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2015
1	Interleukin-17 (Interleukin 17)IBA 05/2015
1	Dihydrotachysterol (AT 10)IBA 05/2015
1	Interleukin-22 (IL-22)IBA 01/2015
1	interleukin-22 receptor (IL-22R)IBA 01/2015
1	Cadherins (E-Cadherin)IBA 11/2014
1	Cycloheximide (Cicloheximide)IBA 11/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2014
1	CSK Tyrosine-Protein KinaseIBA 11/2014
1	F-Box ProteinsIBA 11/2013
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2012
1	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2010
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2009
1	Threonine (L-Threonine)FDA Link 09/2008
1	Arginine (L-Arginine)FDA Link 09/2008
1	CollagenIBA 09/2008
1	Cholinergic ReceptorsIBA 03/2007
1	AntibodiesIBA 03/2007
1	LigandsIBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006
1	Estrogens (Estrogen)FDA Link 09/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2004
1	AutoantigensIBA 02/2003
1	Protein Subunit VaccinesIBA 02/2003

Therapy/Procedure

4	Therapeutics 11/2021 - 03/2007
1	Artificial Respiration (Mechanical Ventilation) 12/2019
1	Drug Therapy (Chemotherapy) 10/2015